Cell Biology of Iron Transport

铁转运的细胞生物学

基本信息

项目摘要

We have used a whole-genome approach to identify genes that are involved in the response to iron deprivation and iron overload in the budding yeast, Saccharomyces cerevisiae. Yeast respond to iron deprivation by activating systems of iron uptake, by mobilizing stored iron, and by shifting to iron-independent metabolic pathways. One type of iron uptake system activated during iron deprivation specifically transports iron-siderophore chelates, such as ferrichrome (FC). The intracellular trafficking of Arn1, a FC transporter in Saccharomyces cerevisiae, is controlled in part by the binding of FC to the transporter. In the absence of FC, Arn1 is sorted directly from the Golgi to endosomes. FC binding triggers the redistribution of Arn1 to the plasma membrane, while FC transport is associated with the cycling of Arn1 between the plasma membrane and endosomes. We determined that the clathrin adaptor Gga2 and ubiquitination by the Rsp5 ubiquitin ligase are required for trafficking of Arn1. Gga2 was required for Golgi to endosomal trafficking of Arn1, which was sorted from endosomes to the vacuole for degradation. Although Gga2 is reported to act as a receptor for ubiquitinated cargo, the binding of ubiquitin residues was not required for Gga2 to mediate trafficking of Arn1. Trafficking into the vacuolar lumen was dependent on ubiquitination by Rsp5, and on the capacity of Gga2 to bind ubiquitin. Retrograde trafficking via the retromer complex or Snx4 was also not required for plasma membrane accumulation. Without this ubiquitination, Arn1 remained on the plasma membrane, where it was active for transport. Arn1 was preferentially modified with poly-ubiquitin chains on a cluster of lysine residues at the amino terminus of the transporter. In order to determine the global cellular requirements for Arn1 trafficking and to identify new cellular components involved in protein trafficking, we have designed a screen to identify all of the open reading frames necessary for proper Arn1 trafficking. In collaboration with Munira Basrai of NCI, we have engineered a GFP-tagged version of Arn1 into the yeast deletion mutant collection, and are using this collection to identify deletion mutants with defects in protein trafficking.
我们已经使用全基因组方法来确定在萌芽酵母中参与铁缺乏和铁超载反应的基因。酵母对缺铁的反应是通过激活铁摄取系统,动员储存的铁,并转移到铁不依赖的代谢途径。在缺铁期间激活的一种铁摄取系统专门运输铁-铁载体螯合物,如铁铬(Fc)。酿酒酵母中Fc转运蛋白Arn1的胞内转运部分受Fc与转运蛋白结合的控制。在没有Fc的情况下,Arn1直接从高尔基体到内体。Fc结合触发Arn1重新分布到质膜,而Fc转运与Arn1在质膜和内体之间的循环有关。我们确定Arn1的运输需要网状蛋白适配器GGa2和Rsp5泛素连接酶的泛素化。高尔基体需要GGa2来运输Arn1,Arn1是从内体分离到液泡中降解的。尽管GGa2被报道为泛素化货物的受体,但GGa2介导Arn1的运输并不需要泛素残基的结合。转运到空泡腔依赖于RSP5的泛素化,以及GGa2结合泛素的能力。通过逆转录复合体或Snx4逆行运输也不是质膜积累所必需的。如果没有这种泛素化,Arn1仍然留在质膜上,在那里它是活跃的运输。Arn1在转运蛋白氨基末端的一簇赖氨酸残基上优先被多泛素链修饰。 为了确定Arn1转运的全球细胞需求,并确定参与蛋白质转运的新的细胞成分,我们设计了一个屏幕来识别正确的Arn1转运所需的所有开放阅读框架。在与NCI的Munira Basrai的合作下,我们已经将GFP标记的Arn1版本设计到酵母缺失突变体库中,并正在使用该库来鉴定具有蛋白质运输缺陷的缺失突变体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Caroline Philpott其他文献

Caroline Philpott的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Caroline Philpott', 18)}}的其他基金

Eukaryotic Heme Utilization
真核血红素利用
  • 批准号:
    7967561
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:
Identification of human genes of iron homeostasis
人类铁稳态基因的鉴定
  • 批准号:
    9361476
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:
Cell Biology of Iron Transport
铁转运的细胞生物学
  • 批准号:
    7967559
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:
Eukaryotic Heme Utilization
真核血红素利用
  • 批准号:
    8553535
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:
Identification of human genes of iron homeostasis
人类铁稳态基因的鉴定
  • 批准号:
    8939621
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:
Eukaryotic Heme Utilization
真核血红素利用
  • 批准号:
    7734202
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:
Identification of human genes of iron homeostasis
人类铁稳态基因的鉴定
  • 批准号:
    10919440
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:
Identification of human genes of iron homeostasis
人类铁稳态基因的鉴定
  • 批准号:
    10006702
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:
Eukaryotic Heme Utilization
真核血红素利用
  • 批准号:
    7593673
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:
Eukaryotic Heme Utilization
真核血红素利用
  • 批准号:
    8148835
  • 财政年份:
  • 资助金额:
    $ 36.54万
  • 项目类别:

相似海外基金

How exercise improves ataxia in SCA6
运动如何改善 SCA6 的共济失调
  • 批准号:
    479005
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Operating Grants
Role of POU4F1 in a Novel Form of Ataxia
POU4F1 在新型共济失调中的作用
  • 批准号:
    10741382
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
Exploratoin of Nrf2 activators that potentiate chaperone-mediated autophagy and are useful for the treatment of spinocrebellar ataxia
探索增强伴侣介导的自噬并可用于治疗脊髓小脑共济失调的 Nrf2 激活剂
  • 批准号:
    23K06161
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
定义 Tox3 在先天性小脑发育不全和共济失调中的作用
  • 批准号:
    10799992
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
共济失调毛细血管扩张症神经发病机制中 R 环的全基因组失调
  • 批准号:
    10607414
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
  • 批准号:
    10753403
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
  • 批准号:
    10668768
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
  • 批准号:
    10579736
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
The Impact of Vitamin D on mTOR Signaling, Seizures, and Motor Behavior in a Mouse Model of Hyperactive mTOR Induced Epilepsy and Ataxia
维生素 D 对 mTOR 过度活跃诱发癫痫和共济失调小鼠模型中 mTOR 信号传导、癫痫发作和运动行为的影响
  • 批准号:
    10754319
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
  • 批准号:
    10740682
  • 财政年份:
    2023
  • 资助金额:
    $ 36.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了